Celebrity Charity Art Book

The Butterfly Book is a collection of butterflies drawn by some of the UK’s most famous artists, designers, writers, actors, politicians and other famous faces.

All the profits from the sale of this book will go to the Claire Elizabeth Wadley Forget-Me-Not Fund for Leukaemia Research. The Butterfly Book has been inspired by the life of Claire Wadley who died at the age of 25 after battling with Leukaemia for seven years.

Claire became heavily involved with raising money for Leukaemia Research and she worked tirelessly even when she was very ill. She overcame her illness several times and each time was determined to live her life to the full. But sadly it came back a final time in 2006 and she lost her valiant battle.

It is such a varied and interesting collection of butterflies. Imaginations have run riot. The butterflies are as varied as the names! Grayson Perry, Kate Winslet, Tony Blair, Peter Blake, Mary Fedden, Maggi Hambling, Ricky Gervais and many other household names make this an art book like no other. Some contributors, including award-winning writers Jeanette Winterson and Ann Widdecombe, have provided poetry and their contributions are incredibly personal and thoughtful.

For more information, email: info@thebutterflybook.co.uk

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap